Zevra Therapeutics, Inc. - ZVRA

SEC FilingsOur ZVRA Tweets

About Gravity Analytica

Recent News

  • 02.03.2026 - Efficacy of Arimoclomol Combined With Miglustat at Months 3, 6, 9 and 12 of the Double-Blind, Randomized, Placebo-Controlled NPC002 Trial

Recent Filings

  • 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 02.02.2026 - 144 Report of proposed sale of securities
  • 01.30.2026 - 144 Report of proposed sale of securities
  • 01.30.2026 - 144 Report of proposed sale of securities
  • 01.30.2026 - 144 Report of proposed sale of securities
  • 01.30.2026 - 144 Report of proposed sale of securities